Sertraline is one of the most widely prescribed antidepressants in the world. Global sertraline sales are expected to keep growing, projected to expand from an estimated US$1.94 billion in 2025 to approximately US$3.13 billion by 2032.
In Brazil, a national survey indicates that 10.2% of Brazilians were diagnosed with depression, and it is estimated that 4% used antidepressants.
